Swiss National Bank Ptc Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 134,865 shares of PTCT stock, worth $6.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,865

Previous 135,665 0.59%

Holding current value

$6.17 Million

Previous $4.15 Million 20.61%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$30.39 - $37.66 $24,312 - $30,127	-800 Reduced 0.59%	134,865 $5 Million
Q2 2024 Aug 08, 2024	BUY	$24.69 - $40.12 $51,849 - $84,252	2,100 Added 1.57%	135,665 $4.15 Million
Q4 2023 Feb 06, 2024	SELL	$18.07 - $29.37 $238,524 - $387,684	-13,200 Reduced 8.99%	133,565 $3.68 Million
Q3 2023 Nov 08, 2023	BUY	$22.41 - $41.99 $47,061 - $88,179	2,100 Added 1.45%	146,765 $3.29 Million
Q2 2023 Aug 09, 2023	BUY	$40.4 - $59.1 $206,040 - $301,410	5,100 Added 3.65%	144,665 $5.88 Million
Q1 2023 May 10, 2023	SELL	$38.16 - $48.86 $606,744 - $776,874	-15,900 Reduced 10.23%	139,565 $6.76 Million
Q4 2022 Feb 08, 2023	BUY	$33.53 - $54.79 $107,296 - $175,328	3,200 Added 2.1%	155,465 $5.93 Million
Q3 2022 Nov 09, 2022	BUY	$41.85 - $53.85 $41,850 - $53,850	1,000 Added 0.66%	152,265 $7.64 Million
Q2 2022 Aug 09, 2022	BUY	$25.6 - $45.23 $20,480 - $36,184	800 Added 0.53%	151,265 $6.06 Million
Q1 2022 May 09, 2022	BUY	$33.33 - $44.6 $343,299 - $459,380	10,300 Added 7.35%	150,465 $5.61 Million
Q3 2021 Nov 08, 2021	BUY	$37.01 - $44.74 $25,907 - $31,318	700 Added 0.5%	140,165 $5.22 Million
Q2 2021 Aug 06, 2021	SELL	$37.95 - $49.37 $30,360 - $39,496	-800 Reduced 0.57%	139,465 $5.9 Million
Q1 2021 May 07, 2021	BUY	$46.8 - $68.92 $117,000 - $172,300	2,500 Added 1.81%	140,265 $6.64 Million
Q4 2020 Feb 05, 2021	BUY	$47.96 - $67.64 $455,620 - $642,580	9,500 Added 7.41%	137,765 $8.41 Million
Q3 2020 Nov 09, 2020	BUY	$45.41 - $57.07 $199,803 - $251,108	4,400 Added 3.55%	128,265 $6 Million
Q2 2020 Aug 05, 2020	BUY	$42.56 - $54.98 $693,728 - $896,174	16,300 Added 15.15%	123,865 $6.29 Million
Q1 2020 May 08, 2020	BUY	$32.37 - $59.36 $194,219 - $356,160	6,000 Added 5.91%	107,565 $4.8 Million
Q4 2019 Feb 06, 2020	BUY	$32.22 - $50.07 $80,550 - $125,175	2,500 Added 2.52%	101,565 $4.88 Million
Q3 2019 Nov 12, 2019	BUY	$33.82 - $48.17 $111,606 - $158,961	3,300 Added 3.45%	99,065 $3.35 Million
Q2 2019 Aug 02, 2019	BUY	$35.42 - $45.0 $70,840 - $90,000	2,000 Added 2.13%	95,765 $4.31 Million
Q1 2019 May 10, 2019	BUY	$28.09 - $39.49 $514,047 - $722,667	18,300 Added 24.25%	93,765 $3.53 Million
Q4 2018 Feb 13, 2019	BUY	$29.83 - $46.51 $196,878 - $306,966	6,600 Added 9.58%	75,465 $2.59 Million
Q3 2018 Nov 08, 2018	BUY	$33.9 - $47.77 $250,860 - $353,498	7,400 Added 12.04%	68,865 $3.24 Million
Q2 2018 Aug 09, 2018	SELL	$25.7 - $47.88 $310,970 - $579,348	-12,100 Reduced 16.45%	61,465 $2.07 Million
Q1 2018 May 04, 2018	BUY	$17.46 - $32.59 $139,680 - $260,720	8,000 Added 12.2%	73,565 $1.99 Million
Q3 2017 Nov 03, 2017	BUY	$16.81 - $21.61 $1.1 Million - $1.42 Million	65,565	65,565 $1.31 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Ptc Therapeutics, Inc. Transaction History